Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
ADC ID |
DRG0KVVMV
|
|||||
---|---|---|---|---|---|---|
ADC Name |
Anti-GPC3 mAb 4A6-IIIb-01
|
|||||
Synonyms |
Anti-GPC3-mAb-4A6-IIIb-01
Click to Show/Hide
|
|||||
Organization |
Bristol Myers Squibb Co.
|
|||||
Drug Status |
Investigative
|
|||||
Indication |
In total 1 Indication(s)
Hepatocellular carcinoma [ICD11:2C12]
Investigative
|
|||||
Drug-to-Antibody Ratio |
2.7
|
|||||
Antibody Name |
Anti-GPC3 mAb 4A6
|
Antibody Info | ||||
Antigen Name |
Glypican-3 (GPC3)
|
Antigen Info | ||||
Payload Name |
Undisclosed
|
|||||
Linker Name |
Anti-GPC3 mAb 4A6-IIIb-01 linker
|
|||||
Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
General Information of The Activity Data Related to This ADC
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | 228.00 pM | Positive GPC3 expression (GPC3+++/++) | ||
Method Description |
The MTS cell proliferation assay was performed as follows: CellTiter 96 Aqueous Non-Radioactive Cell proliferation Kit is used to determine the number of viable cells in cell proliferation assay. Tumor cells are plated at certain seeding densities in sterile 384-well black clear bottom Matrix plates at 40 uL per well and incubated overnight at 37°C in 5% CO2 before assaying.
Click to Show/Hide
|
||||
In Vitro Model | Childhood hepatocellular carcinoma | Hep 3B2.1-7 cells | CVCL_0326 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | 14.00 nM | Negative GPC3 expression (GPC3-) | ||
Method Description |
The MTS cell proliferation assay was performed as follows: CellTiter 96 Aqueous Non-Radioactive Cell proliferation Kit is used to determine the number of viable cells in cell proliferation assay. Tumor cells are plated at certain seeding densities in sterile 384-well black clear bottom Matrix plates at 40 uL per well and incubated overnight at 37°C in 5% CO2 before assaying.
Click to Show/Hide
|
||||
In Vitro Model | Gastric tubular adenocarcinoma | NCI-N87 cells | CVCL_1603 |
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.